Atlas Trials

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Clinical trial NCT04613271 · COMPLETED

Trial details

NCT number
NCT04613271
Sponsor
Ina-Respond
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infectious DiseaseSARS-CoV InfectionCovid19
Start date
2020-10-15
Primary completion
2021-10-25
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.